Skip to main content
Novartis Home

Language & Country Selector for Desktop

language-selector-globe Global | en

Choose Location

  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Global

Choose Location

International Americas Asia Pacific Europe Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About 
      • Board of Directors 
        • Joerg Reinhardt 
        • Simon Moroney 
        • Nancy Andrews 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Andreas von Planta 
        • Charles Sawyers 
        • William Winters 
        • Charlotte Pamer-Wieser 
      • Executive Committee 
        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Klaus Moosmayer 
        • Marie-France Tschudin 
        • Lutz Hegemann 
        • Kees Roks 
        • Richard Saynor 
        • Michael Willi 
      • Strategy 
        • People and Culture 
        • Data and Digital 
      • Products 
      • Innovative Medicines 
      • Sandoz 
      • Diversity, Equity & Inclusion 
        • Equity 
        • Diversity, Equity & Inclusion Governance and Community 
        • Inclusivity 
        • Parental Leave 
        • Society 
      • Manufacturing 
      • Quality 
        • Audit program 
        • Novartis Quality Management System (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Awards and Recognition 
      Male scientist in lab About Novartis
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Patient Organization Funding 
      • COVID-19: Patients and Caregivers 
      • Stories: Patients Perspectives 
      Couple holding hands Patients & Caregivers
    • Healthcare Professionals 
      • Medical Congresses and Events 
        • Abstract summaries for EULAR 
        • Abstract summaries for ACR 
        • Abstract summaries for EADV 
      • Products 
      • Novartis Pipeline 
      • Managed Access Programs 
        • Novartis Gene Therapies Managed Access Program 
      • Novartis External Funding 
      • Healthcare Professional Resources by Country 
      • Investigator-Initiated Trials / Studies 
      • Transparency and Disclosure 
      • Novartis Medical Information 
        • Submit medical enquiry 
      Doctor Healthcare Professionals
    • Research & Development 
      • Novartis Institutes for BioMedical Research 
        • Collaborations 
        • NIBR Global Scholars Program 
      • Technology Platforms 
        • Radioligand Therapy 
        • Gene Therapy 
        • Cell Therapy 
      • Research Disease Areas 
        • Immuno-oncology research at Novartis 
        • Oncology research at Novartis 
        • Cardiovascular and metabolic disease research at Novartis 
        • Autoimmunity, transplantation and inflammatory disease research at Novartis 
        • Ophthalmology research at Novartis 
        • Neuroscience Research at Novartis 
        • Musculoskeletal Disease Research at Novartis 
        • DAx: exploratory disease research at Novartis 
      • Research Locations 
        • Novartis Institute for Tropical Diseases 
      • Novartis Pipeline 
      • Translational Medicine 
      • Research & Development Approach 
      • Research Collaborations 
      • Open Source Science 
      • Stories from our Labs 
      Scientists conducting innovative research experiments Research & Development
    • ESG 
      • Access 
        • Creating sustainable business models 
        • Value-Based Pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis Access Principles 
        • Novartis Oncology Access 
        • Patents and Licensing 
      • Ethics, Risk and Compliance 
        • Ethical Behavior 
        • Compliance 
        • Human Rights 
        • Learning and Engagement 
        • Risk management 
      • Environmental Sustainability 
        • Climate 
        • Waste 
        • Water 
      • Global Health 
        • Anti-Microbial Resistance (AMR) 
        • Avoidable Blindness 
        • Chagas Disease 
        • Leprosy 
        • Malaria 
        • Sickle Cell Disease (SCD) 
        • Novartis Foundation 
      • Diversity, Equity & Inclusion 
      • Reporting 
        • ESG Rating Performance 
        • Codes, Policies and Guidelines 
        • Materiality Assessment 
        • Transparency and Disclosure 
        • Targets 
        • Positions 
      • ESG Index 
      Young patients waiting outside an hospital in Rwanda Environmental, Social and Governance
    • Investors 
      • Event Calendar 
      • Financial Data 
        • Novartis Annual Results 
        • Novartis Quarterly Results 
        • Novartis SEC Filings 
        • Product Sales 
        • Fixed-Income Securities 
        • Expected Currency Impact 
      • Share Data & Analysis 
        • Share Monitor 
        • Dividend Information 
        • Share Ownership 
        • Share Overview 
        • Return On Investment Calculator 
      • Shareholder Information 
        • General Meetings 
        • American Depository Receipts (ADR) 
        • Share Buy-Back 
        • Frequently Asked Questions 
      • Company Overview 
        • Corporate Governance 
      • Novartis Annual Reporting Suite 
        • Reporting Archive 
        • Publications Order Form 
      • ESG 
      Hands marking a test tube Investors
    • News 
      • News Archive  
      • Media Library  
      • Stories 
      • Subscribe 
      People at the table with screens News
    • Careers 
      • Career Search 
      • Our Teams 
        • Careers in Commercial 
        • Careers in Communications and Engagement 
        • Careers in Consulting 
        • Careers in Digital 
        • Careers in Health, Safety & Environment 
        • Careers in Information Technology (IT) 
        • Careers in Medical & Development 
        • Careers in People & Organization 
        • Careers in Procurement 
        • Careers in Research 
        • Careers in Strategy 
        • Careers in Manufacturing and Supply 
        • Ethics, Risk & Compliance (ERC) 
        • Careers in Legal 
      • Career Programs 
        • Community Exploration & Learning Lab (CELL) 
        • Postdoc Program 
      • Early Talent 
        • US NIBR Internship Programs 
      • International Careers 
      • Personal Growth 
      • Well-being 
      A female Novartis researcher Careers
    • Clinical Trials 
      doctor taking the blood pressure of her patient Clinical Trials
    • Partnering 
      Business people working in a dark room Partnering
    • Supplier Portal 
    • Report side effects 
    • Contacts 
      Office Cubicle Contacts
    Group of scientists working in a lab in winter Home
  1. Home
  2. Careers
  3. Career Search
  4. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date
Job Title Site Location Division Business Functional Area Date
Ethics Risk & Compliance Manager Innovative Medicines Mexico Distrito Federal Mexico PHARMA LACAN PHARMA Legal & Intellectual Property & Compl. Jan 31, 2023
Ethics, Risk & Compliance Manager Barcelona Spain PHARMA REGION EUROPE PHARMA Legal & Intellectual Property & Compl. Jan 31, 2023
Director, Data Privacy, Digital & AI (DPDAI) US Advisor East Hanover, NJ USA CORPORATE GROUP LEGAL Legal & Intellectual Property & Compl. Jan 31, 2023
Director, Medical Affairs Counsel - IM US East Hanover, NJ USA PHARMA US PHARMA Legal & Intellectual Property & Compl. Jan 30, 2023
Country Head ERC Amsterdam Netherlands PHARMA REGION EUROPE PHARMA Legal & Intellectual Property & Compl. Jan 26, 2023
Head Legal GDD Japan Tokyo Japan PHARMA Japan Legal & Intellectual Property & Compl. Jan 26, 2023
Juriste (CDD) H/F Levallois-Perret France SANDOZ COMMERCIAL OPS EUROPE SZ Legal & Intellectual Property & Compl. Jan 25, 2023
Senior Manager Legal Operations, Vendor relations Prague Czech Republic SANDOZ COMMERCIAL OPS EUROPE SZ Legal & Intellectual Property & Compl. Jan 24, 2023
Senior Manager Legal Operations, Processes and Systems Prague Czech Republic SANDOZ COMMERCIAL OPS EUROPE SZ Legal & Intellectual Property & Compl. Jan 24, 2023
ERC M&S Campus Business partner (f/m/d) Kundl Austria Novartis Technical Operations NTO LEGAL Legal & Intellectual Property & Compl. Jan 24, 2023
Director Ethics, Risk and Compliance R&D Hyderabad, AP India Global Drug Development MGMT OFFICE GDD Legal & Intellectual Property & Compl. Jan 23, 2023
Director, Ethics, Risk & Compliance Advisor- Multiple positions East Hanover, NJ USA PHARMA US PHARMA Legal & Intellectual Property & Compl. Jan 23, 2023
Associate Director, Legal Innovation and Operations East Hanover, NJ USA CORPORATE GROUP LEGAL Legal & Intellectual Property & Compl. Jan 20, 2023
Senior Ethics, Risk and Compliance (ERC) Manager National United Kingdom SANDOZ COMMERCIAL OPS EUROPE SZ Legal & Intellectual Property & Compl. Jan 20, 2023
Ethics Risk & Compliance Manager Mumbai India PHARMA AMAC Legal & Intellectual Property & Compl. Jan 19, 2023
Head Data Privacy Russia Moscow Russian Fed. ONCOLOGY ONCOLOGY BU Legal & Intellectual Property & Compl. Jan 19, 2023
(Senior) IP Counsel Princeton, NJ USA SANDOZ COMMERCIAL OPS NA SZ Legal & Intellectual Property & Compl. Jan 19, 2023
Legal Counsel London-West United Kingdom PHARMA REGION EUROPE PHARMA Legal & Intellectual Property & Compl. Jan 19, 2023
Global Head Risk, Security and Resilience (d/f/m) Holzkirchen (near Munich) Germany SANDOZ Ethics, Risk & Compliance SZ Legal & Intellectual Property & Compl. Jan 18, 2023
Associate Director, Global Security & Healthcare Compliance Investig. East Hanover, NJ USA CORPORATE BUSINESS ASSURANCE AND ADVISORY Legal & Intellectual Property & Compl. Jan 18, 2023
Associate Director, Global Security & Healthcare Compliance Investig. East Hanover, NJ USA CORPORATE BUSINESS ASSURANCE AND ADVISORY Legal & Intellectual Property & Compl. Jan 18, 2023
Sr Manager - Ethics Risk & Compliance Manager Mumbai India PHARMA AMAC Legal & Intellectual Property & Compl. Jan 17, 2023
Juriste senior H/F Levallois-Perret France SANDOZ COMMERCIAL OPS EUROPE SZ Legal & Intellectual Property & Compl. Jan 13, 2023
Manager Hyderabad, AP India CTS CONEXTS Legal & Intellectual Property & Compl. Jan 13, 2023
Ethics Risk & Compliance Manager Riyadh Saudi Arabia PHARMA AMAC Legal & Intellectual Property & Compl. Jan 12, 2023
ERC Governance & Operations Specialist Athens Greece PHARMA REGION EUROPE PHARMA Legal & Intellectual Property & Compl. Jan 11, 2023
Director, Product Strategy Counsel - IM US East Hanover, NJ USA ONCOLOGY ONCOLOGY BU Legal & Intellectual Property & Compl. Jan 11, 2023
Ethics, Risk & Compliance Manager Región Metropolitana Chile PHARMA LACAN PHARMA Legal & Intellectual Property & Compl. Jan 11, 2023
Patent Attorney II - Biology, R&D Cambridge, MA USA NIBR CAO - NIBR Legal & Intellectual Property & Compl. Jan 10, 2023
Patent Docketing & Annuities Paralegal Cambridge, MA USA NIBR CAO - NIBR Legal & Intellectual Property & Compl. Jan 10, 2023
Manager, HCP Fair Market Value East Hanover, NJ USA PHARMA US PHARMA Legal & Intellectual Property & Compl. Jan 06, 2023
Director, Ethics Risk & Compliance Integrated Mktg Multiple Positions East Hanover, NJ USA PHARMA US PHARMA Legal & Intellectual Property & Compl. Jan 04, 2023
HEAD DPDA BRAZIL – IM - SP Sao Paulo - Matriz Brazil PHARMA LACAN PHARMA Legal & Intellectual Property & Compl. Jan 04, 2023
ERC Specialst, Monitoring Shanghai China SANDOZ Commercial OPS SIR SZ Legal & Intellectual Property & Compl. Dec 27, 2022
Senior Manager Legal Operations, Projects (d/f/m) Holzkirchen (near Munich) Germany SANDOZ Global Legal SZ Legal & Intellectual Property & Compl. Dec 21, 2022
Group Lead, Compliance & Risk Operations Hyderabad, AP India CTS CONEXTS Legal & Intellectual Property & Compl. Dec 20, 2022
Country Head of Legal Cairo Egypt PHARMA AMAC Legal & Intellectual Property & Compl. Dec 18, 2022
Director, Ethics Risk & Compliance Advisor- Patient Services East Hanover, NJ USA PHARMA US PHARMA Legal & Intellectual Property & Compl. Dec 09, 2022
Associate Director, ERC Policy and Learning Princeton, NJ USA SANDOZ COMMERCIAL OPS NA SZ Legal & Intellectual Property & Compl. Dec 05, 2022
Country Legal Head, IM Philippines Metro Manila Philippines PHARMA AMAC Legal & Intellectual Property & Compl. Dec 04, 2022
Legal Counsel, ANZ Sydney Australia PHARMA AMAC Legal & Intellectual Property & Compl. Nov 15, 2022
Director, Patient Services Counsel (NJ or Remote) East Hanover, NJ USA PHARMA US PHARMA Legal & Intellectual Property & Compl. Nov 15, 2022
Legal Counsel Frimley / Camberley United Kingdom SANDOZ COMMERCIAL OPS EUROPE SZ Legal & Intellectual Property & Compl. Nov 09, 2022
Global Security Investigations, AD Shanghai China CORPORATE BUSINESS ASSURANCE AND ADVISORY Legal & Intellectual Property & Compl. Nov 03, 2022

Novartis

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • Researchers
  • Job Seekers
  • Journalists
  • Investors
  • Partners
  • Suppliers
Topics
  • Clinical Trials
  • COVID-19 Info Center
  • ESG
Explore
  • Stories
  • Diseases
  • Locations
  • Products
  • Novartis Pipeline
Novartis companies
  • Sandoz
  • Advanced Accelerator Applications
  • Gyroscope Therapeutics
Footer Bottom
© 2023 Novartis AG
  • Terms of Use
  • Privacy
  • Contacts
  • Cookie Settings
  • Site Map
  • Web Accessibility
  • Open Source
Novartis Site Directory
This site is intended for a global audience